Advertisement
Screener

OUTLOOK THERAPEUTICS, INC. (OTLK) Cash Flow Breakdown

OUTLOOK THERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where OUTLOOK THERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-09-30: from running the business, $51.83M went out.
  • Fiscal year ended 2025-09-30: from financing, $44.98M came in.
  • Fiscal year ended 2025-09-30: change in cash, $6.84M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2025-09-30-$51.83M-$36.14M$33.10M$25.40M$22.63M*-$6.84M
2024-09-30-$68.79M$60.33M-$8.46M
2023-09-30-$42.97M-$10.22M$30.00M$30.02M-$835.64K*$6.00M
2022-09-30-$56.67M-$12.29M$10.00M$62.31M$2.92M
2021-09-30-$54.25M-$50.28K$10.00M$46.30M$1.94M
2020-09-30-$31.79M-$900.00K-$48.20K$904.20K$35.43M$923.83K*$4.52M
2019-09-30-$32.29M-$437.31K-$6.42M$45.96M-$521.74K*$6.30M
2018-09-30-$33.04M-$2.78M-$127.74K$14.70M$19.79M*-$1.47M
2017-09-30-$15.51M-$292.09K-$2.68M$1.61M$17.70M*$833.63K
2016-09-30-$45.48M-$1.10M-$1.06M$200.42K-$71.76K$16.14M$24.65M*-$6.72M
2015-09-30-$27.48M-$8.80M-$725.60K$41.25M$2.48M*$6.72M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$21.01M*$25.20M*$1.41M*
2026-03-31-$7.83M*$6.90M*
2025-12-31-$14.94M$14.93M$601.91K*$594.34K
2025-09-30-$12.38M*-$2.33M*$0.00*$7.64M*$6.25M*
2025-06-30-$11.90M*-$906.98K*$0.00*$14.60M*
2025-03-31-$16.58M*$1.42M*$17.02M*
2024-12-31-$10.97M$1.74M-$9.22M
2024-09-30-$16.98M*-$114.95K*
2024-06-30-$19.51M*$4.31M*
2024-03-31-$19.27M*$56.14M*
2023-12-31-$13.03M-$13.04M
2023-09-30-$12.74M*$0.00*$0.00*$2.43M*
2023-06-30-$13.22M*$0.00*$0.00*$3.30M*
2023-03-31-$8.11M*$0.00*$0.00*-$339.27K*
2022-12-31-$8.90M-$10.22M$30.00M$24.64M-$571.73K*$34.94M
2022-09-30-$10.25M*$0.00*$0.00*$1.63M*
2022-06-30-$21.10M*-$11.59M*$0.00*$293.00K*
2022-03-31-$14.33M*-$301.40K*$0.00*$2.73M*
2021-12-31-$10.99M-$401.87K$10.00M$57.65M-$589.05K*$55.67M
2021-09-30-$8.99M*$3.60M*$0.00*$3.79M*
2021-06-30-$20.19M*-$12.67K*$0.00*$2.73M*
2021-03-31-$11.75M*-$12.30K*$0.00*$43.36M*
2020-12-31-$13.32M-$3.62M$10.00M-$6.97M
2020-09-30-$12.08M*$0.00*-$12.57K*$0.00*$691.46K*
2020-06-30-$5.96M*-$12.22K*$25.28M*$886.00K*
2020-03-31-$7.08M*-$11.87K*$10.41M*
2019-12-31-$6.67M-$11.54K-$6.68M
2019-09-30-$5.94M*-$1.00*-$13.05K*$1.00*
2019-06-30-$10.31M*-$150.74K*-$1.78M*$26.16M*$13.87M*
2019-03-31-$6.26M*-$50.14K*-$1.50M*$7.92M*-$72.25K*
2018-12-31-$9.78M-$236.43K-$3.13M$11.89M-$1.49M
2018-09-30-$8.39M*-$1.26M*-$33.31K*-$160.97K*-$10.08M*
2018-06-30-$8.54M*-$168.02K*-$32.42K*$14.60M*$5.86M*
2018-03-31-$7.44M*-$275.19K*-$31.55K*-$7.90M*
2017-12-31-$8.67M-$1.08M-$30.46K$20.43M*$10.65M
2017-09-30$79.85K*-$23.98K*-$12.05K*$0.00*$3.00M*$3.05M*
2017-06-30-$5.63M*-$76.23K*-$37.31K*$927.61K*$4.88M*$58.85K*
2017-03-31-$4.11M*-$43.52K*-$48.56K*$2.21M*-$2.00M*
2016-12-31-$5.84M-$148.36K-$2.58M$8.30M*-$273.35K
2016-09-30-$10.37M*-$328.41K*-$507.75K*$0.00*$0.00*-$11.20M*
2016-06-30-$16.04M*-$452.48K*-$186.94K*$0.00*$0.00*$27.39M*$10.71M*
2016-03-31-$7.06M*$46.95K*-$184.29K*$0.00*$4.82M*-$2.74M*
2015-12-31-$12.01M-$364.24K-$180.06K-$71.76K$11.32M-$2.18M*-$3.49M
2015-09-30-$11.01M*-$3.29M*-$176.87K*$23.25M*-$5.07M*$3.69M*
2015-06-30-$10.04M*-$3.49M*-$172.98K*$18.65M*$4.95M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48